tirzepatide surmount 2 SURMOUNT-2: Demonstrates Body Weight-Lowering Effects in T2D Surmount-5 - Page 1 |

Originally developed to help adults with type 2 diabetes manage their blood sugar, it has become widely recognized for its weight loss benefits

Prefer treatments researched in human fertility populations

The 10mg dose is commonly used in research to explore these effects, though exact results can vary depending on the study setup

most patients see appetite reduction in days 12 but no scale movement until week 23

Aerobic exercise capacity is not affected by GH at physiologic doses in healthy individuals (reviewed here (Chikani and Ho, 2014)) or in AGHD patients (Chikani, Cuneo, Hickman et al., 2016)

Which flu vaccines are available this year